CN103491898B - 用于工业规模分散的生物基质支架 - Google Patents

用于工业规模分散的生物基质支架 Download PDF

Info

Publication number
CN103491898B
CN103491898B CN201180042690.1A CN201180042690A CN103491898B CN 103491898 B CN103491898 B CN 103491898B CN 201180042690 A CN201180042690 A CN 201180042690A CN 103491898 B CN103491898 B CN 103491898B
Authority
CN
China
Prior art keywords
biomatrix
cells
tissue
collagen
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180042690.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN103491898A (zh
Inventor
M·L·罗亚奇
R·H·马拉瓦卡
Y·王
L·C·M·里德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GIGACYTE LLC
University of North Carolina at Chapel Hill
Original Assignee
GIGACYTE LLC
University of North Carolina at Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GIGACYTE LLC, University of North Carolina at Chapel Hill filed Critical GIGACYTE LLC
Publication of CN103491898A publication Critical patent/CN103491898A/zh
Application granted granted Critical
Publication of CN103491898B publication Critical patent/CN103491898B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0671—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/28—Materials or treatment for tissue regeneration for liver reconstruction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/14—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20051—Methods of production or purification of viral material
    • C12N2710/20052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10151—Methods of production or purification of viral material
    • C12N2730/10152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24223—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material
    • C12N2770/24252—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Enzymes And Modification Thereof (AREA)
CN201180042690.1A 2010-07-02 2011-07-01 用于工业规模分散的生物基质支架 Expired - Fee Related CN103491898B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36093910P 2010-07-02 2010-07-02
US61/360939 2010-07-02
PCT/US2011/042825 WO2012003463A1 (en) 2010-07-02 2011-07-01 Biomatrix scaffolds for industrial scale dispersal

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510751844.4A Division CN105713868A (zh) 2010-07-02 2011-07-01 用于工业规模分散的生物基质支架

Publications (2)

Publication Number Publication Date
CN103491898A CN103491898A (zh) 2014-01-01
CN103491898B true CN103491898B (zh) 2015-11-25

Family

ID=45402468

Family Applications (4)

Application Number Title Priority Date Filing Date
CN201180042690.1A Expired - Fee Related CN103491898B (zh) 2010-07-02 2011-07-01 用于工业规模分散的生物基质支架
CN201610286180.3A Pending CN106362211A (zh) 2010-07-02 2011-07-01 生物基质支架
CN2011800426899A Pending CN103249404A (zh) 2010-07-02 2011-07-01 生物基质支架
CN201510751844.4A Pending CN105713868A (zh) 2010-07-02 2011-07-01 用于工业规模分散的生物基质支架

Family Applications After (3)

Application Number Title Priority Date Filing Date
CN201610286180.3A Pending CN106362211A (zh) 2010-07-02 2011-07-01 生物基质支架
CN2011800426899A Pending CN103249404A (zh) 2010-07-02 2011-07-01 生物基质支架
CN201510751844.4A Pending CN105713868A (zh) 2010-07-02 2011-07-01 用于工业规模分散的生物基质支架

Country Status (11)

Country Link
US (7) US9102913B2 (https=)
EP (6) EP3192862B1 (https=)
JP (7) JP2013539960A (https=)
CN (4) CN103491898B (https=)
DK (2) DK2588027T3 (https=)
ES (6) ES2946590T3 (https=)
HU (2) HUE032730T2 (https=)
LT (2) LT2588083T (https=)
PL (2) PL2588027T3 (https=)
PT (2) PT2588027T (https=)
WO (2) WO2012003450A2 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2588027T3 (pl) * 2010-07-02 2017-09-29 The University Of North Carolina At Chapel Hill Rusztowania biomacierzowe do rozpraszania na skalę przemysłową
NL2009145C2 (en) * 2012-07-06 2014-01-07 Xeltis B V Implant.
CN103536967B (zh) * 2012-07-10 2016-04-13 上海微创医疗器械（集团）有限公司 一种制备细胞外基质支架材料的脱细胞方法
US9533013B2 (en) 2013-03-13 2017-01-03 University Of North Carolina At Chapel Hill Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree
JP2016513465A (ja) * 2013-03-15 2016-05-16 ミロマトリックス メディカル インコーポレイティド 膵島細胞の再細胞化のための灌流型脱細胞化肝臓の使用
AU2014228022B9 (en) * 2013-03-15 2016-11-03 NuTech Medical, Inc. Preparations derived from placental materials of making and using same
ES2703785T3 (es) * 2013-04-08 2019-03-12 Regentys Corp Método y composición para tratar una enfermedad inflamatoria intestinal sin colectomía
US20150037436A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
CN103432627B (zh) * 2013-08-26 2015-03-25 北京瑞健高科生物科技有限公司 一种制备动物脱细胞组织基质材料的方法及其制备的组织基质材料
EP3122872B1 (en) 2014-03-27 2019-07-03 The Salk Institute for Biological Studies Compositions and methods for treating type 1 and type 2 diabetes and related disorders
GB201409858D0 (en) * 2014-06-03 2014-07-16 Ucl Business Plc Human liver scaffolds
CN104288837B (zh) * 2014-09-11 2016-04-13 杨淑珍 一种脱细胞真皮基质及其制备方法和用途
AU2016225076B2 (en) 2015-02-27 2018-09-13 Salk Institute For Biological Studies Reprogramming progenitor compositions and methods of use therefore
CN104928241B (zh) * 2015-03-27 2018-04-13 北京康爱瑞浩生物科技股份有限公司 一种增强型nk细胞的活化方法及细胞制备方法
WO2016200340A1 (en) 2015-06-12 2016-12-15 Agency For Science, Technology And Research Derivation of hepatic stem cells and mature liver cell types and uses thereof
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
CN106884002B (zh) * 2015-12-15 2021-03-19 上海市针灸经络研究所 一种稳定的结肠上皮细胞培养方法
CN105833353B (zh) * 2016-05-09 2018-04-20 拜欧迪赛尔（北京）生物科技有限公司 一种生物工程脱细胞真皮基质的制备及用途
US20170369849A1 (en) * 2016-05-11 2017-12-28 The University Of North Carolina At Chapel Hill Compositions and methods for bioengineered tissues
US11760977B2 (en) 2016-05-25 2023-09-19 Salk Institute For Biological Studies Compositions and methods for organoid generation and disease modeling
KR20190028726A (ko) * 2016-07-12 2019-03-19 더 유니버시티 오브 노스캐롤라이나 앳 채플 힐 암 진단 및 모델링에 사용하기 위한 바이오매트릭스 스캐폴드
CN106362212A (zh) * 2016-10-21 2017-02-01 华中科技大学同济医学院附属协和医院 一种用于去除组织细胞的亲脂性去细胞溶液、试剂盒和方法
GB2555787A (en) * 2016-11-07 2018-05-16 Landberg Goran Diagnostic methods
CN116243006A (zh) * 2016-11-30 2023-06-09 布鲁克·道尔顿有限及两合公司 制备活的微生物样品和微生物用于随后的质谱测量和评估
WO2018144469A1 (en) * 2017-01-31 2018-08-09 University Of Vermont And State Agricultural College Avian based lung assist device
CN111032090A (zh) * 2017-06-12 2020-04-17 北卡罗来纳大学教堂山分校 用于细胞植入的补片植入物组合物
ES2938458T3 (es) * 2017-07-31 2023-04-11 Canto Zago Alexandre Do Dispositivo y método para promover la cobertura rápida de malla estructural y la cobertura endotelial vascular
EP3470096A1 (en) * 2017-10-13 2019-04-17 Erasmus University Medical Center Rotterdam Elastin reduction allowing recellularization of cartilage implants
WO2019129646A1 (en) * 2017-12-29 2019-07-04 F. Hoffmann-La Roche Ag Tissue sample preparation system
EP3813896B1 (en) * 2018-05-14 2025-10-01 Roosterbio, Inc. Methods and compositions related to extracellular material derived from hypertonic cell solutions
WO2019241499A1 (en) 2018-06-13 2019-12-19 Miromatrix Medical Inc. Fistula filler and deployment system
CN108753687B (zh) * 2018-06-22 2021-04-16 中国人民解放军军事科学院军事医学研究院 微肝组织培养模型、其构建方法及其应用
CN108753686B (zh) * 2018-06-22 2021-06-22 中国人民解放军军事科学院军事医学研究院 组织工程肝脏模型、其构建方法及其应用
CN109735490A (zh) * 2019-03-06 2019-05-10 福建省海西细胞生物工程有限公司 一种脂肪干细胞提取方法
CN110257335B (zh) * 2019-04-10 2020-09-29 首都医科大学附属北京天坛医院 单层或多层的3d脑胶质瘤细胞培养模型及其构建方法和应用
EP4712098A2 (en) 2019-05-16 2026-03-18 ResMed Pty Ltd Two-way communication in a medical device
KR102360023B1 (ko) * 2019-09-04 2022-02-09 한국생명공학연구원 증식 가능한 간 오가노이드
CN110559485B (zh) * 2019-09-25 2021-02-02 北京大清生物技术股份有限公司 一种生物组织基质材料及其制备方法与应用
DE102019130568A1 (de) 2019-11-13 2021-05-20 Aesculap Ag Chirurgischer Fräser mit verbesserter Spanabfuhr
CN118846235A (zh) * 2019-12-30 2024-10-29 广东泓志生物科技有限公司 大网膜脱细胞基质材料的制备方法及软骨组织的构建方法
EP4098739A4 (en) 2020-02-14 2024-03-20 Cellartgen Inc. SCAFFOLD FROM DECELLULARIZED ORGANIC TISSUE, FOR THE CULTURE AND TRANSPLANTATION OF ORGANOIDS, AND ASSOCIATED PRODUCTION METHOD
CN111760072B (zh) * 2020-08-24 2022-09-23 鲁峰 脂肪来源的真皮内填充物及其制备和应用
GB202102232D0 (en) * 2021-02-17 2021-03-31 Cambridge Entpr Ltd Methods of Expanding Cholangiocytes
CN114748208B (zh) * 2022-04-15 2024-01-12 柔脉医疗(深圳)有限公司 一种可原位检测多种化学、生物成分的组织工程支架
CN115948331B (zh) * 2022-10-17 2024-10-22 中国人民解放军西部战区总医院 一种从小鼠胆囊中分离获取间充质干细胞的方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115208A1 (en) * 2000-08-16 2002-08-22 Shannon Mitchell Decellularized tissue engineered constructs and tissues
US20020177551A1 (en) * 2000-05-31 2002-11-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US20050058631A1 (en) * 2003-06-27 2005-03-17 Kihm Anthony J. Postpartum cells derived from placental tissue, and methods of making and using the same
CN1777437A (zh) * 2003-02-21 2006-05-24 Uab研究基金会 生物活性天然生物基质组合物
CN101182464A (zh) * 2006-05-16 2008-05-21 贝克顿·迪金森公司 用于细胞培养的经细胞外基质包被的表面
CN101237898A (zh) * 2005-06-10 2008-08-06 细胞基因公司 人胎盘胶原组合物、其制备方法、使用方法以及包含该组合物的试剂盒
CN101238249A (zh) * 2005-08-10 2008-08-06 东丽株式会社 海绵状结构体和粉末以及它们的制造方法
WO2010039823A2 (en) * 2008-09-30 2010-04-08 The Regents Of The University Of California Compositions and methods for tissue repair with extracellular matrices

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19569C (de) ANNA ERBER in Brieg Neuerungen an der unter Nr. 17581 patentirten Handlaterne
CA2155186A1 (en) * 1993-02-01 1994-08-18 Kevin M. Ulmer Methods and apparatus for dna sequencing
US5695998A (en) * 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US6149891A (en) 1995-05-31 2000-11-21 Israel Humanitarian Foundation Ltd. X-ray contrast medium and method for protecting against harmful effects thereof
EP3246396B1 (en) 2001-02-14 2020-01-29 Celularity, Inc. Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
JP4426285B2 (ja) 2001-06-28 2010-03-03 クック・バイオテック・インコーポレーテッド 腎被膜コラーゲンを含有する移植片プロテーゼ用具
US20040187877A1 (en) * 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of liver tissue
CA2530490A1 (en) 2003-06-25 2005-01-13 Stephen F. Badylak Conditioned matrix compositions for tissue restoration
US9944900B2 (en) 2006-01-18 2018-04-17 Hemacell Perfusion Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
US8685107B2 (en) * 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
US20120064050A1 (en) * 2009-02-04 2012-03-15 Yale University Tissue Engineering of Lung
WO2010099463A2 (en) * 2009-02-27 2010-09-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Joint bioscaffolds
EP2588592B1 (en) 2010-06-30 2017-09-06 Miromatrix Medical Inc. Use of perfusion decellularized organs for matched recellularization
PL2588027T3 (pl) * 2010-07-02 2017-09-29 The University Of North Carolina At Chapel Hill Rusztowania biomacierzowe do rozpraszania na skalę przemysłową

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020177551A1 (en) * 2000-05-31 2002-11-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US20020115208A1 (en) * 2000-08-16 2002-08-22 Shannon Mitchell Decellularized tissue engineered constructs and tissues
CN1777437A (zh) * 2003-02-21 2006-05-24 Uab研究基金会 生物活性天然生物基质组合物
US20050058631A1 (en) * 2003-06-27 2005-03-17 Kihm Anthony J. Postpartum cells derived from placental tissue, and methods of making and using the same
CN101237898A (zh) * 2005-06-10 2008-08-06 细胞基因公司 人胎盘胶原组合物、其制备方法、使用方法以及包含该组合物的试剂盒
CN101238249A (zh) * 2005-08-10 2008-08-06 东丽株式会社 海绵状结构体和粉末以及它们的制造方法
CN101182464A (zh) * 2006-05-16 2008-05-21 贝克顿·迪金森公司 用于细胞培养的经细胞外基质包被的表面
WO2010039823A2 (en) * 2008-09-30 2010-04-08 The Regents Of The University Of California Compositions and methods for tissue repair with extracellular matrices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Embryonic Stem Cells Proliferate and Differentiate when Seeded into Kidney Scaffolds;ROSS et al;《J Am soc Nephrol》;20091130;第20卷(第11期);第2338-2347页 *

Also Published As

Publication number Publication date
ES2946590T3 (es) 2023-07-21
JP2018143249A (ja) 2018-09-20
US20130195811A1 (en) 2013-08-01
JP2017079757A (ja) 2017-05-18
EP3581171B1 (en) 2022-03-09
EP3581171A1 (en) 2019-12-18
US20160024463A1 (en) 2016-01-28
EP2588027A1 (en) 2013-05-08
HK1243928A1 (en) 2018-07-27
JP6612722B2 (ja) 2019-11-27
EP3603622B1 (en) 2023-03-08
LT2588083T (lt) 2017-06-12
WO2012003450A3 (en) 2012-04-05
HUE032727T2 (en) 2017-10-30
US9944896B2 (en) 2018-04-17
PL2588027T3 (pl) 2017-09-29
WO2012003450A2 (en) 2012-01-05
CN103491898A (zh) 2014-01-01
PT2588083T (pt) 2017-06-26
EP3192862A1 (en) 2017-07-19
EP2588083A2 (en) 2013-05-08
EP3603622A1 (en) 2020-02-05
US9102913B2 (en) 2015-08-11
JP2013535961A (ja) 2013-09-19
US20130137176A1 (en) 2013-05-30
EP2588027A4 (en) 2013-12-11
PT2588027T (pt) 2017-06-23
EP2588027B8 (en) 2017-07-26
US10640747B2 (en) 2020-05-05
EP2588083A4 (en) 2013-11-13
ES2791312T3 (es) 2020-11-03
DK2588083T3 (en) 2017-06-19
CN103249404A (zh) 2013-08-14
JP2013539960A (ja) 2013-10-31
HUE032730T2 (en) 2017-10-30
EP2588027B1 (en) 2017-03-08
JP6308781B2 (ja) 2018-04-11
EP3216444B1 (en) 2020-03-11
EP3192862B1 (en) 2021-04-07
DK2588027T3 (en) 2017-06-19
JP6527272B2 (ja) 2019-06-05
EP2588083B1 (en) 2017-03-08
ES2624742T3 (es) 2017-07-17
EP3216444A1 (en) 2017-09-13
ES2626145T3 (es) 2017-07-24
JP2017055764A (ja) 2017-03-23
US20200002667A1 (en) 2020-01-02
WO2012003463A1 (en) 2012-01-05
HK1193018A1 (zh) 2014-09-12
CN106362211A (zh) 2017-02-01
ES2879246T3 (es) 2021-11-22
JP2019017392A (ja) 2019-02-07
US20150110753A1 (en) 2015-04-23
JP2019017393A (ja) 2019-02-07
US20190024043A1 (en) 2019-01-24
US20170015974A1 (en) 2017-01-19
US8802081B2 (en) 2014-08-12
US10246678B2 (en) 2019-04-02
LT2588027T (lt) 2017-06-12
CN105713868A (zh) 2016-06-29
PL2588083T3 (pl) 2017-08-31
ES2916580T3 (es) 2022-07-01

Similar Documents

Publication Publication Date Title
CN103491898B (zh) 用于工业规模分散的生物基质支架
HK1193018B (en) Biomatrix scafolds for industrial scale dispersal
HK1233552A1 (en) Biomatrix scaffolds
HK1180235B (en) Biomatrix scaffolds
HK1180235A (en) Biomatrix scaffolds
HK1243928B (en) Biomatrix scaffolds for industrial scale dispersal
HK40023076B (en) Biomatrix scaffolds for industrial scale dispersal
HK1180206B (en) Biomatrix scaffolds for industrial scale dispersal
HK1180206A (en) Biomatrix scaffolds for industrial scale dispersal
HK40023076A (en) Biomatrix scaffolds for industrial scale dispersal
HK1188143A (en) Biomatrix scaffolds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1193018

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1193018

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151125

Termination date: 20200701